Scientists create a cell that precludes malignant growth
Scientists at the University of Helsinki developed a cell preventing malignant growth, enhancing therapies for diseases like diabetes. Engineered cells show promise in regulating glucose levels and evading immune rejection, advancing safer cell therapies.
Read original article
Scientists at the University of Helsinki have developed a groundbreaking cell that prevents malignant growth. This innovation aims to enhance cell therapies for various diseases, including hereditary conditions and diabetes. By modifying stem cells to only divide in the presence of a specific component, the researchers have created cells that cannot proliferate independently, reducing the risk of cancer. These engineered cells have shown promising results in regulating blood glucose levels and differentiating into various tissue types. The technique not only ensures safe cell editing but also opens up possibilities for creating universally compatible cells that evade immune rejection. Published in Molecular Therapy, this research represents a significant step towards safer and more effective cell therapies to combat diseases and tissue damage. The study's findings offer hope for the development of novel treatments using these engineered cells, bringing us closer to realizing the potential of regenerative medicine.
Related
New technique opens the door to large-scale DNA editing to cure diseases
Researchers have described a new genetic editing mechanism using jumping genes to insert DNA sequences accurately. This system shows promise in overcoming CRISPR limitations, with 94% accuracy and 60% efficiency in bacteria. Optimizations are needed for mammalian cell use.
Computer-designed proteins guide stem cells to form blood vessels
Researchers at the University of Washington developed computer-designed proteins to guide stem cells in forming blood vessels, showing promise in regenerative medicine for organ repair. The study highlights potential advancements in tissue development research.
Light targets cells for death and triggers immune response with laser precision
Researchers at the University of Illinois Urbana-Champaign developed a method using light to induce inflammatory cell death, potentially aiding cancer and inflammatory disease treatments. The precise technique triggers immune responses for therapeutic applications.
Trying to outrun her disease, researcher creates powerful epigenetic editor
A powerful epigenetic editor developed by researchers at the Broad Institute aims to combat prion disease, a rare neurodegenerative condition. The tool utilizes CRISPR gene editing to potentially treat this fatal disease.
Re-engineering cancerous tumors to self-destruct and kill drug-resistant cells
Researchers at Penn State University developed a genetic circuit to re-engineer cancerous tumors, causing self-destruction and targeting drug-resistant cells. Published in Nature Biotechnology, the study shows promising results in combating cancer evolution and drug resistance.
5 commentshttps://www.cell.com/molecular-therapy-family/molecular-ther...
Or what are other types of uses for these cells?
Related
New technique opens the door to large-scale DNA editing to cure diseases
Researchers have described a new genetic editing mechanism using jumping genes to insert DNA sequences accurately. This system shows promise in overcoming CRISPR limitations, with 94% accuracy and 60% efficiency in bacteria. Optimizations are needed for mammalian cell use.
Computer-designed proteins guide stem cells to form blood vessels
Researchers at the University of Washington developed computer-designed proteins to guide stem cells in forming blood vessels, showing promise in regenerative medicine for organ repair. The study highlights potential advancements in tissue development research.
Light targets cells for death and triggers immune response with laser precision
Researchers at the University of Illinois Urbana-Champaign developed a method using light to induce inflammatory cell death, potentially aiding cancer and inflammatory disease treatments. The precise technique triggers immune responses for therapeutic applications.
Trying to outrun her disease, researcher creates powerful epigenetic editor
A powerful epigenetic editor developed by researchers at the Broad Institute aims to combat prion disease, a rare neurodegenerative condition. The tool utilizes CRISPR gene editing to potentially treat this fatal disease.
Re-engineering cancerous tumors to self-destruct and kill drug-resistant cells
Researchers at Penn State University developed a genetic circuit to re-engineer cancerous tumors, causing self-destruction and targeting drug-resistant cells. Published in Nature Biotechnology, the study shows promising results in combating cancer evolution and drug resistance.